HIV Drugs Found In Kenya Despite Crackdown On Counterfeits

Nairobi: Kenyan authorities issued a warning Wednesday about the sale of counterfeit HIV prevention drugs in the country, saying their “safety, quality and efficacy cannot be assured.”

The Pharmacy and Poisons Board said the drugs were in two batches falsely labeled as Truvada, a commonly used HIV prevention  worldwide.

The board said on X, formerly Twitter, that it will take “stern legal and regulatory action” against anyone found trading, distributing, selling or dispensing from the batches.

Kenyan police fear that thousands of counterfeits of Truvada could already be in circulation on the market.

Around 1.4 million people have HIV in Kenya, according to UNAIDS data in 2022. Of those, 1.2 million are on antiretroviral therapy drugs.

Truvada is manufactured by U.S.-based Gilead Sciences Inc., which in January warned that millions of dollars’ worth of fake versions of its HIV drugs were being sold in the U.S., posing dangers to patients.

But their discovery in Kenya, East Africa’s commercial hub, shows the herculean task of tackling fake medicines.

Truvada is used in treating HIV and as a preexposure prophylaxis for people at high risk, including those with multiple  and those who share needles while injecting drugs.

Earlier this month, Kenya’s National Syndemic Diseases Control Council, a state body charged with coordinating national strategy for HIV and AIDS, raised the alarm that HIV infection rates among those ages 15 to 29 had surged by 61% between 2021 and 2022.

Across Africa,  have expressed concern about complacency as AIDS treatment improves.

Related Posts

  • Pharma
  • June 21, 2024
  • 52 views
Indian Pharmacopoeia Commission Flags ADR Linked To Meropenem

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of May, has revealed that the carbapenem antibiotic Meropenem is linked with adverse drug…

  • Pharma
  • June 21, 2024
  • 62 views
Plan To Regulate Nutraceutical Industry Underway

NEW DELHI: India’s foods regulator is working on a draft regulation to clearly demarcate nutraceuticals and pharmaceutical drugs, to eliminate ambiguity and ensure that health supplements that are borderline pharma…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Indian Pharmacopoeia Commission Flags ADR Linked To Meropenem

Indian Pharmacopoeia Commission Flags ADR Linked To Meropenem

Plan To Regulate Nutraceutical Industry Underway

Plan To Regulate Nutraceutical Industry Underway

Ayush And Herbal Products Exports Grow Over 20% In April

Ayush And Herbal Products Exports Grow Over 20% In April

NMC Says No Antibiotics Before Diagnostic Tests

NMC Says No Antibiotics Before Diagnostic Tests

Health, Drug Control Officials To Monitor Sale Of Abortion Kits

Health, Drug Control Officials To Monitor Sale Of Abortion Kits

Punjab: 11-Month-Old Given Expired Vaccine At Amritsar’s Private Hospital

Punjab: 11-Month-Old Given Expired Vaccine At Amritsar’s Private Hospital